1〔1〕 Mankin HJ, Springfield DS, Gebhardt MC:Current status of allografting for bone tumors[J]. Orthopedics, 1992:(15) 1147～1154.
2〔2〕Bacci G, Ferrari S, Mercuri M: Predictive factors for local recurrence inosteosarcoma[J].Acta Orthop Scand 1998:230～236.〔3〕 Load CF, Gebhardt MC, Tomford WW: Infection in bone allogra ft[J]. J.Boneand Joint Surg(Am). 1988 70(3):369～376.
3〔4〕 Mankin HJ: The clinical use of frozen cadaveric allografts in the management ofbone tumors: An overview. In: Limb Salvage. Majior reconstr uctions in oncologic andnontumoral conditions[C]. p3～7 Edited by F. Langlais and B.Tomeno. New York,Springer, 1991.
4〔5〕 Mankin HJ, Doppelt SH, Tomford WW: Clinical experience with allograftimplantation. The first ten years[J]. Clin Orthop 174: 69～74. 198 3
5〔6〕 Cruz EO, Gebhardt MC, Jennings C: The results of transplant ation of intercalaryallografts after resection of tumors[J]. J. Bone and Joi nt Surg(Am)., 79(1):97～106,1997.
6〔7〕 Fitzgerald RH: Antibiotic distribution in nomal and osteomy elitic bone[J].Orthop. Clin. North America, 15:537～546, 1984.
(收稿：1999-12-28 修回：2000-03-16)
9Finkemeier C G. Bone-grafting and bone-graft substitutes[J]. J Bone Joint Surg,2002,84A(3) :454-464.
10Gross A E,Blackley H,Wong P, et al. The use of allografts in orthopaedic surgery. Part Ⅱ : The role of allografts in revision arthroplasty of the hip[J]. J Bone Joint Surg, 2002,84A(4) : 655-677.
